Search results
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 14 hours agoLife360 (NASDAQ: LIF), a San Francisco-based tracking app company, was featured in a recent Fox Business article. The article highlighted the company’s debut as a public company, noting that ...
PC Maker Raspberry Pi Seen Pricing London IPO at Top End of Range
Bloomberg· 1 day agoBritish personal computer maker Raspberry Pi expects to price its London initial public offering at...
Aramco Offering Weighs on Biggest Saudi IPO Debut of Year
Bloomberg via Yahoo Finance· 2 days ago(Bloomberg) -- Saudi Aramco’s $12 billion secondary share sale took the shine off the kingdom’s...
Ixigo IPO To Open Next Week: Indian OTA Aims to Raise $89 Million
Skift· 3 days agoLe Travenues Technology, the parent company of Indian travel aggregator Ixigo, will be launching its...
J&J-backed Rapport Therapeutics valued at $636.8 mln in lukewarm debut
Reuters· 12 hours agoJohnson & Johnson-backed Rapport Therapeutics' shares rose nearly 6% above the initial public offering price on Friday, in a tepid debut for the early-stage therapy developer.
Rapport Therapeutics raises up to $154 million in IPO - Boston Business Journal
The Business Journals· 22 hours agoRapport Therapeutics Inc. said late Thursday it has raised $154 million in an initial public offering. Rapport (Nasdaq: RAPP), a Boston-based maker of small-molecule medicines for patients with ...
Life360 Announces 5.75M Share IPO at $27/sh By Investing.com
Investing.com· 2 days agoLife360 Announces 5.75M Share IPO at $27/sh
Aluminum Producer Novelis Hits Pause on $945 Million US IPO
Bloomberg via Yahoo Finance· 3 days ago(Bloomberg) -- Aluminum producer Novelis Inc. has postponed a plan to raise as much as $945 million...
Analyst Report: DocuSign, Inc.
Morningstar Research via Yahoo Finance· 18 hours agoDocusign offers Agreement Cloud, a broad cloud-based software suite that enables users to automate the agreement process and provide legally binding e-signatures from nearly any device. The ...
J&J-backed Rapport Therapeutics valued at $636.8 million in lukewarm debut
Reuters via Yahoo News· 17 hours agoU.S. IPOs are seeing a rebound this year, after an almost two-year dry spell when high interest rates, market volatility and geopolitical turmoil marred investors' risk appetite. Among other ...
